最新の財務諸表(Form-10K)によると、Apyx Medical Incの総資産は$0で、純損失は$0です。
APYXの主要な財務比率は何ですか?
Apyx Medical Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Apyx Medical Incの収益はセグメントまたは地域別にどのように分けられていますか?
Apyx Medical Inc の最大収益セグメントは Surgical Aesthetics で、最新の利益発表における収益は 45,332,000 です。地域別に見ると、United States が Apyx Medical Inc の主要市場であり、収益は 38,801,000 です。
Apyx Medical Incは収益を上げていますか?
いいえ、最新の財務諸表によると、Apyx Medical Incの純損失は$0です。
Apyx Medical Incに負債はありますか?
いいえ、Apyx Medical Incの負債は0です。
Apyx Medical Incの発行済株式数は何株ですか?
Apyx Medical Incの総発行済株式数は0株です。
主要データ
前終値
$4.11
始値
$4.07
当日レンジ
$3.96 - $4.11
52週レンジ
$1.55 - $4.68
取引高
160.2K
平均取引高
158.0K
配当利回り
--
1株当たり利益(TTM)
-0.22
時価総額
$167.8M
APYXとは何ですか?
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 205 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.